Ignite Creation Date:
2024-05-06 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 12:50 PM
Study NCT ID:
NCT03613168
Status:
COMPLETED
Last Update Posted:
2021-01-05
First Post:
2018-07-28
Brief Title:
Trastuzumab in HER2-positive Biliary Tract Cancer
Sponsor:
Changhoon Yoo
Organization:
Asan Medical Center
Organization Data
Organization:
Asan Medical Center
Class:
OTHER
Study ID:
BTC-HER2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Changhoon Yoo
Lead Sponsor Class:
OTHER
Responsible Party:
Changhoon Yoo
Responsible Party Title:
Assistant professor
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Asan Medical Center
Old Name:
None
Old Organization:
None